EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Quantification of impact of COVID-19 pandemic on cancer screening programmes – a case study from Argentina, Bangladesh, Colombia, Morocco, Sri Lanka, and Thailand

Eric Lucas iD, Raul Murillo iD, Silvina Arrossi, Martin Bárcena, Youssef Chami, Ashrafun Nessa, Suraj Perera, Padmaka Silva, Suleeporn Sangrajrang, Richard Muwonge, Partha Basu iD

eLife · 16.05.2023 · 12

DOI: 10.7554/elife.86527 ↗

Kurz gefasst

Fachartikel in der Zeitschrift eLife, online erschienen am 16.05.2023. Verfasst von Eric Lucas und 10 weiteren Autor:innen. Beteiligte Einrichtung: International Agency for Research on Cancer, Lyon, France. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, COVID-19. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: World Health Organization.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

It is quite well documented that the COVID-19 pandemic disrupted cancer screening services in all countries, irrespective of their resources and healthcare settings. While quantitative estimates on reduction in volume of screening tests or diagnostic evaluation are readily available from the high-income countries, very little data are available from the low- and middle-income countries (LMICs). From the CanScreen5 global cancer screening data repository we identified six LMICs through purposive sampling based on the availability of cancer screening data at least for the years 2019 and 2020. These countries represented those in high human development index (HDI) categories (Argentina, Colombia, Sri Lanka, and Thailand) and medium HDI categories (Bangladesh and Morocco). No data were available from low HDI countries to perform similar analysis. The reduction in the volume of tests in 2020 compared to the previous year ranged from 14.1% in Bangladesh to 72.9% in Argentina (regional programme) for cervical screening, from 14.2% in Bangladesh to 49.4% in Morocco for breast cancer screening and 30.7% in Thailand for colorectal cancer screening. Number of colposcopies was reduced in 2020 compared to previous year by 88.9% in Argentina, 38.2% in Colombia, 27.4% in Bangladesh, and 52.2% in Morocco. The reduction in detection rates of CIN 2 or worse lesions ranged from 20.7% in Morocco to 45.4% in Argentina. Reduction of breast cancer detection by 19.1% was reported from Morocco. No association of the impact of pandemic could be seen with HDI categories. Quantifying the impact of service disruptions in screening and diagnostic tests will allow the programmes to strategize how to ramp up services to clear the backlogs in screening and more crucially in further evaluation of screen positives. The data can be used to estimate the impact on stage distribution and avoidable mortality from these common cancers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Uterine Cervical NeoplasmsCOVID-19FemaleHumansThailandEarly Detection of CancerPandemicsBangladeshSri LankaArgentinaColombiaMoroccoDeveloping Countries

Stichwörter der Autor:innen

COVID-19cancer screeningepidemiologyglobal healthimpactlow- and middle-income countriesnone

Autor:innen und Institutionen

  • International Agency for Research on Cancer, Lyon, France.
  • Hospital Universitario San Ignacio, Bogota, Colombia.
  • Investigadora CEDES/CONICET, Buenos Aires, Argentina.
  • Instituto Provincial del Cáncer, Jujuy, Argentina.
  • Foundation Lalla Salma Cancer prevention and treatment, Rabat, Morocco.
  • Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh.

ORCID-Profile: Eric Lucas, Raul Murillo, Partha Basu

Förderung

  • World Health Organization

Zitieren

APA

Lucas, E., Murillo, R., Arrossi, S., Bárcena, M., Chami, Y., Nessa, A., Perera, S., Silva, P., Sangrajrang, S., Muwonge, R., & Basu, P. (2023). Quantification of impact of COVID-19 pandemic on cancer screening programmes – a case study from Argentina, Bangladesh, Colombia, Morocco, Sri Lanka, and Thailand. eLife, 12. https://doi.org/10.7554/elife.86527

Vancouver

Lucas E, Murillo R, Arrossi S, Bárcena M, Chami Y, Nessa A, et al. Quantification of impact of COVID-19 pandemic on cancer screening programmes – a case study from Argentina, Bangladesh, Colombia, Morocco, Sri Lanka, and Thailand. eLife. 2023;12. doi:10.7554/elife.86527

BibTeX
@article{Lucas2023,
  author = {Lucas, Eric and Murillo, Raul and Arrossi, Silvina and Bárcena, Martin and Chami, Youssef and Nessa, Ashrafun and Perera, Suraj and Silva, Padmaka and Sangrajrang, Suleeporn and Muwonge, Richard and Basu, Partha},
  title = {Quantification of impact of COVID-19 pandemic on cancer screening programmes – a case study from Argentina, Bangladesh, Colombia, Morocco, Sri Lanka, and Thailand},
  journal = {eLife},
  year = {2023},
  volume = {12},
  doi = {10.7554/elife.86527}
}
Kostenlos starten →